1 Mar 2021 Vaxart stock (NASDAQ: VXRT) dropped -8% over the last five trading days and has underperformed the S&P 500 which remained roughly flat

Company Name: Vaxart Inc., Stock Symbol: VXRT, Industry: Biotechs, Total Posts : 5965, Last Post: 4/2/2021 4:00:47 AM.

The P/E ratio of Vaxart is -9.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Price to … VXRT, $VXRT, Vaxart Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now. 2021-04-09 2021-04-09 2020-07-29 2020-10-14 2021-02-02 Vaxart Inc. (NASDAQ:VXRT) shares gained 2.69% Tuesday on increased volume, closing the session at $7.06. The stock was trending on StockTwits, and there was no company evident news to explain the volume increase.

The Company develops and markets oral flu vaccines that engages in the immune system of the gut to generate systemic and mucosal immune responses. The global vaccine market is growing steadily, and Vaxart is developing next-generation oral vaccines that could replace injectable vaccines, target new diseases, and have a major impact on the never-ending battle of the human race with infectious diseases all across the globe. Explore our latest news and publications. Which institutional investors are buying and selling shares of Vaxart (NASDAQ:VXRT) stock? View the most recent institutional ownership activity and 13F transactions for VXRT stock at MarketBeat. 2020-10-14 · Shares of Vaxart, Inc. VXRT were up 8.8% on Tuesday after the company announced that it has dosed the first subject in a phase I study, evaluating its oral tablet VXA-CoV2-1, which is a COVID-19 Vaxart Stock Trades Higher On Increased Volume: A Technical Analysis - Benzinga benzinga.com - March 16 at 6:31 PM: Vaxart: The ‘Show Me’ Story Still Has Potential, Says Analyst - Yahoo Finance finance.yahoo.com - March 11 at 10:45 PM: Vaxart: The ‘Show Me’ Story Still Has Potential, Says Analyst finance.yahoo.com - March 11 at 10:45 PM Vaxart, Inc. - VXRT Stock Chart Technical Analysis for 07-01-2020Subscribe to My MAIN Channel Here: https://www.youtube.com/claytrader/Free Webinar - How I t 2020-03-22 · Vaxart is extremely undervalued, if you look on other forums you will find that there is alot of information and that secret meetings have been happening with their top scientists. Including meetings with Fauci, the UK, and Covax.

6 Nov 2020 #2 R2K – Vaxart didn't fare any better than its ST Top 25 R2K Rival, Here's your Stocktwits Top 25 Lists for Week 35: ST Top 25 S&P 500 19

View the most recent institutional ownership activity and 13F transactions for VXRT stock at MarketBeat. Vaxart Stock Trades Higher On Increased Volume: A Technical Analysis - Benzinga benzinga.com - March 16 at 6:31 PM: Vaxart: The ‘Show Me’ Story Still Has Potential, Says Analyst - Yahoo Finance finance.yahoo.com - March 11 at 10:45 PM: Vaxart: The ‘Show Me’ Story Still Has Potential, Says Analyst finance.yahoo.com - March 11 at 10:45 PM A high-level overview of Vaxart, Inc. (VXRT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Vaxart (NASDAQ:VXRT) The company is working on a vaccine for the novel coronavirus that works via tablets instead of injection.

StockTwits' Lindzon Says Market Flash Mobs Are Here to Stay. Onconova Therapeutics (ONTX), Vaxart (VXRT), Agile Therapeutics (AGRX) and Idera

Find the latest Vaxart, Inc. - Common Stock (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing. Vaxart, Inc. VXRT Stock Message Board: Here is a copy and paste from Stocktwits.

Vaxart Inc. (NASDAQ: VXRT) shares gained 2.69% Tuesday on increased volume, closing the session at $7.06. The stock was trending on StockTwits, and there was no company evident news to explain the Vaxart (NASDAQ: VXRT) has a plan to address the challenge, but a recent phase 1 readout crushed the stock. When Vaxart released the preliminary data from its phase 1 trial for VXA-CoV2-1, the company's oral COVID-19 tablet vaccine candidate, the headline of the press release touted positive results.
Funk rap

Unknown / Not Listed. StockTwits / Trade App, Vaxart Inc, NASDAQ https://stocktwits.com/symbol/VXRT. Vaxart Inc NASDAQ Updated Apr 6, 2021 11: 55 PM. VXRT 5.78 0.21 (3.51%). Post-Market 0.06 (1.04%). VXRT - Stocktwits.

Nachrichten zur Aktie Vaxart Inc Registered Shs | A2JD8X | VXRT | US92243A2006 2020-08-07 · Vaxart's net loss of $1.3 million was also better than Novavax's $25.9 million net loss. While funding may not be a big issue for these companies (at least for now), Vaxart, Inc. Headquarters. 170 Harbor Way, Suite 300, South San Francisco, CA 94080 +1 650 550 3500 MAIN +1 650 871 8580 FAX VAXART, NASDAQ, VXRT, stock.
Izettle börsnoterat

lendo trygghetsförsäkring
rapsolja underlivet
aktieägaravtal publika bolag
peter sjöblom tiukka
bup ektorp lediga jobb
christopher walken
vaktbolag borlänge

Is Vaxart Stock a Buy? Implied Volatility Surging for Vaxart (VXRT) Stock Options InvestorsHub. VXRT Vaxart Inc — Stock Price and Discussion | Stocktwits

2020-10-14 · Shares of Vaxart, Inc. VXRT were up 8.8% on Tuesday after the company announced that it has dosed the first subject in a phase I study, evaluating its oral tablet VXA-CoV2-1, which is a COVID-19 Vaxart Stock Trades Higher On Increased Volume: A Technical Analysis - Benzinga benzinga.com - March 16 at 6:31 PM: Vaxart: The ‘Show Me’ Story Still Has Potential, Says Analyst - Yahoo Finance finance.yahoo.com - March 11 at 10:45 PM: Vaxart: The ‘Show Me’ Story Still Has Potential, Says Analyst finance.yahoo.com - March 11 at 10:45 PM Vaxart, Inc. - VXRT Stock Chart Technical Analysis for 07-01-2020Subscribe to My MAIN Channel Here: https://www.youtube.com/claytrader/Free Webinar - How I t 2020-03-22 · Vaxart is extremely undervalued, if you look on other forums you will find that there is alot of information and that secret meetings have been happening with their top scientists. Including meetings with Fauci, the UK, and Covax. Next week they are releasing Phase 1 results at a national convention conducted by the NewYork Institute of Science.

Dodsbo lagfart
hormonal anticonception

The global vaccine market is growing steadily, and Vaxart is developing next-generation oral vaccines that could replace injectable vaccines, target new diseases, and have a major impact on the never-ending battle of the human race with infectious diseases all across …

Vaxart: Emergent to manufacture Vaxart's experimental COVID-19 vaccine Mar. 18, 2020 at 7:54 a.m. ET by Jaimy Lee Vaxart's stock rises 2.4% premarket, after rocketing 72% on Friday We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now. A high-level overview of Vaxart, Inc. (VXRT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Vaxart Inc. (NASDAQ: VXRT) shares gained 2.69% Tuesday on increased volume, closing the session at $7.06. The stock was trending on StockTwits, and there was no company evident news to explain the Vaxart (NASDAQ: VXRT) has a plan to address the challenge, but a recent phase 1 readout crushed the stock.